https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-har-utsett-valberedning-infor-arsstamman-2027 2026-10-28 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-bjuder-in-till-investor-and-scientific-update-i-stockholm-och-goteborg-den-12-respektive-13-november 2026-10-13 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-presenterar-pa-kommande-investerarmoten 2026-09-22 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-for-januari-juni-2026 2026-08-25 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-okar-antalet-studiecenter-for-att-accelerera-patientrekryteringen-i-cancerstudie 2026-08-24 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-inleder-sista-doskohorten-i-pagaende-klinisk-fas-ib-studie-av-arfolitixorin 2026-07-08 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kommunike-fran-arsstamma-i-isofol-medical-ab-publ-den-19-maj-2026 2026-05-19 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-for-januari-mars-2026 2026-05-19 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=nytt-antal-aktier-och-roster-i-isofol-1 2026-04-30 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-den-19-maj-2026-i-isofol-medical-ab-publ-2 2026-04-15 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-optimerar-designen-av-sin-fas-ib-ii-studie-efter-nytt-regulatoriskt-godkannande 2026-04-15 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2025 2026-04-10 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-erhaller-bruttolikvid-om-18-9-msek-i-samband-med-optionsinlosen-och-garantiatagande-for-teckningsoptioner-av-serie-to1-samt-beslutar-om-riktad-nyemission 2026-03-31 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-sakrar-licensrattigheter-for-arfolitixorin-inom-autism 2026-03-18 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=teckningskursen-for-teckningsoptioner-av-serie-to1-i-isofol-har-faststallts-till-0-48-sek-och-nyttjandeperioden-inleds-den-16-mars-2026 2026-03-13 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-erhaller-toppgarantiatagande-och-avsiktsforklaringar-motsvarande-42-procent-av-kommande-optionsinlosen 2026-03-11 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-valberedning-foreslar-nyval-av-christian-haglund 2026-03-09 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-presenterar-pa-investerarmoten-i-mars 2026-03-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-lamnar-uppdatering-fran-pagaende-klinisk-fas-ib-ii-studie-av-arfolitixorin 2026-02-24 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-bokslutskommunike-for-januari-december-2025 2026-02-18 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medverkar-pa-cancermotet-asco-gi 2026-01-09 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-deltar-i-flera-investerarmoten-i-december-och-januari 2025-12-01 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=europeiska-patentverket-avser-bevilja-ett-nytt-patent-for-isofols-arfolitixorin 2025-11-13 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-september-2025 2025-11-12 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-har-utsett-valberedning-infor-arsstamman-2026 2025-11-04 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-bjuder-in-till-investerarmote-den-13-november-2025 2025-10-28 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medverkar-pa-cancerkongressen-esmo 2025-10-16 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-kliniska-studie-av-arfolitixorin-nar-annu-ett-viktigt-delmal 2025-09-30 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-slutfor-transaktion-av-aktier-till-solasia-pharma-efter-framgangsrik-foretradesemission 2025-09-26 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-juni-2025 2025-08-26 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-bjuder-in-till-presentation-av-delarsrapporten-for-andra-kvartalet-2025 2025-08-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=nytt-antal-aktier-och-roster-i-isofol 2025-07-31 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-har-genomfort-ett-framgangsrikt-pre-ind-mote-med-fda-for-arfolitixorin 2025-07-16 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-foretradesemission-overtecknad-utnyttjar-overtilldelning-till-japansk-samarbetspartner 2025-07-04 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-offentliggor-prospekt-i-samband-med-bolagets-foretradesemission 2025-06-17 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-slutfor-forsta-kohorten-i-pagaende-klinisk-studie-med-arfolitixorin 2025-06-12 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kommunike-fran-extra-bolagsstamma-i-isofol-medical-ab-publ-den-11-juni-2025 2025-06-11 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-offentliggor-slutliga-villkor-i-foretradesemission-samt-for-en-potentiell-overtilldelningsemission 2025-06-05 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-uppstart-av-nytt-advisory-board-i-samband-med-asco-2025 2025-06-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-beviljas-pre-ind-mote-med-fda-for-arfolitixorin 2025-06-02 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kommunike-fran-arsstamma-i-isofol-medical-ab-publ-den-21-maj-2025 2025-05-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-mars-2025 2025-05-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=intervju-med-isofols-vd-petter-segelman-lindqvist-om-forestaende-foretradesemission 2025-05-14 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-extra-bolagsstamma-den-11-juni-2025-i-isofol-medical-ab-publ 2025-05-12 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=styrelsen-i-isofol-beslutar-om-en-fullt-garanterad-foretradesemission-av-units-om-cirka-85-miljoner-kronor-samt-foreslar-en-overtilldelningsemission-om-cirka-10-miljoner-kronor 2025-05-12 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-inkluderar-forsta-patienten-i-en-klinisk-fas-ib-ii-studie-med-arfolitixorin 2025-04-28 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-den-21-maj-2025-i-isofol-medical-ab-publ-1 2025-04-17 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2024 2025-04-11 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-partner-solasia-avser-utoka-investeringen-i-kommande-studier-av-arfolitixorin 2025-04-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-etablerar-advisory-board-med-ledande-experter 2025-03-27 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-erhaller-myndighetsgodkannande-for-att-inleda-klinisk-studie-med-arfolitixorin 2025-03-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-utokar-natverk-av-radgivare-med-framstaende-expert 2025-03-17 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-presenterar-pa-stora-aktiedagarna-den-12-mars 2025-03-12 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-presenterar-vid-flera-kommande-investerarmoten 2025-03-05 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-bokslutskommunike-januari-december-2024 2025-02-19 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-anstaller-roger-tell-som-medicinsk-chef-infor-start-av-klinisk-studie 2025-02-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-att-en-post-hoc-analys-av-fas-iii-studien-agent-publicerats-som-abstract-vid-asco-gi-2025 2025-01-27 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-och-samarbetspartnern-solasia-planerar-att-expandera-den-kommande-kliniska-studien-av-arfolitixorin-till-japan 2024-12-18 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-tillkannager-att-en-provarinitierad-studie-av-arfolitixorin-har-publicerats-i-bjc-reports 2024-11-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-lamnar-en-operationell-uppdatering-under-investerarmote 2024-11-20 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-har-utsett-valberedningen-infor-arsstamman-2025 2024-11-19 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-september-2024 2024-11-12 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-tillkannager-att-ett-abstract-accepterats-for-presentation-pa-asco-gi-2025 2024-11-11 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-bjuder-in-till-investerarmote-den-20-november-2024 2024-10-25 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=ett-late-breaking-abstract-rorande-arfolitixorin-presenteras-pa-ena-2024-idag 2024-10-23 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-tillkannager-att-ett-late-breaking-abstract-accepterats-for-presentation-pa-ena-2024 2024-10-09 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-starker-utsikterna-for-utokat-patentskydd-av-lakemedelskandidaten-arfolitixorin 2024-09-17 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-avslutar-avtal-om-likviditetsgaranti 2024-09-12 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-halvarsrapport-januari-juni-2024 2024-08-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-utser-margareta-hagman-till-ny-chief-financial-officer 2024-07-30 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-att-nya-prekliniska-data-stoder-den-tidigare-annonserade-kliniska-utvecklingsplanen-for-arfolitixorin 2024-07-16 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-att-en-post-hoc-analys-per-protokoll-av-agent-studien-ger-ytterligare-stod-for-arfolitixorins-fortsatta-kliniska-utveckling 2024-07-05 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-chief-financial-officer-lamnar-bolaget 2024-06-12 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-och-charite-har-tecknat-ett-samarbetsavtal-om-vidare-klinisk-utveckling-av-arfolitixorin 2024-05-24 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kommunike-fran-arsstamma-i-isofol-medical-ab-publ-den-8-maj-2024 2024-05-08 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-mars-2024 2024-05-08 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2023 2024-04-16 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-den-8-maj-2024-i-isofol-medical-ab-publ 2024-04-05 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-japanska-partner-solasia-har-beslutat-att-intensifiera-sitt-engagemang-i-den-kliniska-utvecklingen-av-arfolitixorin 2024-03-19 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-presenterar-en-klinisk-utvecklingsplan-for-arfolitixorin 2024-03-19 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-bjuder-in-till-investerarmote-den-19-mars 2024-03-01 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-bokslutskommunike-januari-december-2023-6852017c 2024-02-20 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=styrelsen-i-isofol-inleder-planeringen-av-kliniska-studier-och-kommer-att-annonsera-en-strategisk-utvecklingsplan-den-19-mars-26411071 2024-02-14 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-utser-magnus-hurst-till-ny-chief-financial-officer-848478b1 2024-01-10 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-utser-petter-segelman-lindqvist-till-ny-verkstallande-direktor-8bb2fac7 2024-01-09 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kommunike-fran-extra-bolagsstamma-i-isofol-medical-ab-publ-den-4-januari-2024-25c841ae 2024-01-04 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-presenterar-ytterligare-resultat-fran-laboratorietester-med-arfolitixorin-som-visar-tillaggseffekter-9314b301 2023-12-28 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=styrelsen-i-isofol-meddelar-sin-installning-till-minoritetsaktieagares-forslag-infor-extra-bolagsstamma-19c0b004 2023-12-13 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-har-tagit-del-av-de-forsta-resultaten-fran-laboratorieforsok-med-arfolitixorin-49a2e569 2023-12-07 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-avvecklar-dotterbolag-530a92b2 2023-12-01 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-extra-bolagsstamma-i-isofol-medical-ab-publ-den-4-januari-2024-3a68efad 2023-11-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-september-2023-913cb909 2023-11-10 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-har-erhallit-begaran-om-att-kalla-till-extra-bolagsstamma-33192125 2023-11-09 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-har-utsett-valberedningen-infor-arsstamman-2024-65734603 2023-11-08 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-har-tagit-del-av-resultatet-fran-modelle-001-studien-b471d444 2023-10-05 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-halvarsrapport-januari-juni-2023-bc1b3549 2023-08-22 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-presenterar-slutsatser-fran-den-fordjupade-analysen-av-agent-studien-30890d72 2023-07-04 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-styrelse-utser-roger-tell-som-tillforordnad-vd-for-bolaget-d40af209 2023-06-22 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=vd-avgar-pa-egen-begaran-i-isofol-medical-ab-publ-f7c7f5b3 2023-06-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=forandring-i-styrelsen-hos-isofol-medical-ab-publ-febe4a48 2023-06-07 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kommunike-fran-arsstamma-i-isofol-medical-ab-publ-den-3-maj-2023-25789e42 2023-05-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-mars-2023-6ec8e198 2023-05-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-inleder-preklinisk-utvardering-av-arfolitixorin-med-oncosyne-as-b7079ab9 2023-04-28 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-isofols-delarsrapport-for-forsta-kvartalet-2023-7812beec 2023-04-25 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2022-6a08ba61 2023-04-06 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-den-3-maj-2023-i-isofol-medical-ab-publ-883c8d0e 2023-04-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-utser-roy-jonebrant-till-ny-tillforordnad-chief-financial-officer-9fc6da18 2023-03-17 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-initierar-en-stegvis-process-for-den-fortsatta-utvecklingen-av-lakemedelskandidaten-arfolitixorin-99f4f7ee 2023-03-06 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-styrelse-utser-thomas-andersson-till-ny-vd-for-foretaget-e13f478f 2023-02-28 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kommunike-fran-extra-bolagsstamma-i-isofol-medical-ab-publ-den-28-februari-2023-644e344c 2023-02-28 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-bokslutskommunike-januari-december-2022-95b80dd0 2023-02-22 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kommunike-fran-extra-bolagsstamma-i-isofol-medical-ab-publ-den-13-februari-2023-20c5ea35 2023-02-13 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-isofols-delarsrapport-for-fjarde-kvartalet-2022-dccb1120 2023-02-09 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-extra-bolagsstamma-i-isofol-medical-ab-publ-den-28-februari-2023-6a0af8f8 2023-02-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-har-erhallit-en-begaran-om-att-kalla-till-extra-bolagsstamma-e4f2ba4e 2023-01-30 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-bjuder-in-till-informationsmote-den-30-januari-infor-extra-bolagsstamma-73ca1aa4 2023-01-20 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-extra-bolagsstamma-i-isofol-medical-ab-publ-den-13-februari-2023-c7bef4c3 2023-01-19 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-styrelse-avser-kalla-till-extra-bolagsstamma-med-forslag-till-utdelning-och-likvidation-av-bolaget-c778270d 2023-01-19 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medicals-cfo-och-vice-vd-gustaf-albert-lamnar-under-2023-977371e7 2022-12-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medicals-vd-ulf-jungnelius-slutar-den-1-juni-2023-1a6e3d7a 2022-11-28 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=agent-studiens-slutliga-data-bekraftar-topline-resultaten-0bdc688c 2022-11-25 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-september-2022-470cc380 2022-11-11 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-har-utsett-valberedningen-infor-arsstamman-2023-3c818564 2022-11-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-isofols-delarsrapport-for-tredje-kvartalet-2022-93a1414b 2022-10-27 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-redovisar-data-fran-agent-studien-57f58055 2022-09-07 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-tillkannager-statusuppdatering-kring-agent-studien-b8ec27ef 2022-08-31 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-halvarsrapport-januari-juni-2022-b707d591 2022-08-23 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-isofols-delarsrapport-for-andra-kvartalet-2022-753be1ea 2022-08-15 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-tillkannager-toplineresultat-fran-fas-iii-studien-agent-varken-det-primara-eller-det-viktigaste-sekundara-effektmatten-uppnaddes-64c91fca 2022-08-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-erhaller-patentgodkannande-for-biomarkoranalys-och-avsikt-att-bevilja-godkannande-av-patentansokan-for-studiedosregim-i-europa-545d3104 2022-07-26 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-justerar-starttiden-for-det-livesanda-fou-eventet-den-20-juni-till-kl-14-00-0fecd98b 2022-06-17 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-arrangerar-livesant-fou-evenemang-den-20-juni-kl-12-30-eea45cd1 2022-06-14 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kommunike-fran-arsstamma-i-isofol-medical-ab-publ-den-19-maj-2022-e47a8ef9 2022-05-19 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=vd-anforande-infor-arsstamma-2022-har-publicerats-19b75cad 2022-05-17 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-mars-2022-7474bd81 2022-05-12 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-isofols-delarsrapport-for-forsta-kvartalet-2022-32053596 2022-05-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2021-df657412 2022-04-27 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-paborjar-analysen-av-studiedata-fran-fas-iii-studien-agent-inom-metastaserad-kolorektalcancer-1cd90d62 2022-04-22 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-den-19-maj-2022-i-isofol-medical-ab-publ-956a5998 2022-04-12 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-valberedning-foreslar-ny-ordforande-c905f594 2022-04-08 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-bokslutskommunike-januari-december-2021-269f3093 2022-02-24 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=inbjudan-till-presentation-av-isofols-bokslutskommunike-2021-den-24-februari-2022-09add3e9 2022-02-14 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-uppmarksammar-varldscancerdagen-den-4-februari-10cf049f 2022-02-04 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-utser-jenny-sundqvist-till-chief-commercial-officer-cco-3b913d8b 2021-12-10 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-bjuder-in-till-audiocast-den-6-december-klockan-08-00-cet-8a431d67 2021-12-05 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-nar-inte-300-pfs-handelser-i-agent-studien-med-nuvarande-censureringsregler-baserat-pa-fda-beslut-7e978c16 2021-12-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-beviljas-fast-track-designation-av-fda-for-arfolitixorin-for-behandling-av-avancerad-kolorektal-cancer-e79fbd65 2021-11-23 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-har-utsett-valberedningen-infor-arsstamman-2022-6e261f2b 2021-11-19 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-september-2021-0f4c7d8f 2021-11-11 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=handeln-i-isofols-aktier-inleds-idag-pa-nasdaq-stockholm-97a93cee 2021-10-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-offentliggor-prospekt-och-ny-finansiell-information-i-samband-med-notering-pa-nasdaq-stockholm-ebe711b2 2021-10-18 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-avser-att-notera-sina-aktier-pa-nasdaq-stockholm-d4041332 2021-10-15 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=foretagspresentation-i-samband-med-lsx-nordic-congress-2021-a0f31713 2021-09-22 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-halvarsrapport-januari-juni-2021-8d463168 2021-08-24 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kommunike-fran-arsstamma-i-isofol-medical-ab-publ-den-23-juni-2021-f834434c 2021-06-23 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=vd-anforande-infor-arsstamma-2021-har-publicerats-f4ef6a26 2021-06-18 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=andring-av-styrelsens-forslag-till-arsstamman-2021-avseende-bemyndigande-a9a8084f 2021-06-14 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-tillfors-500-miljoner-kronor-genom-overtecknad-foretradesemission-och-utnyttjad-overtilldelningsoption-72a81f1f 2021-06-14 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-offentliggor-prospekt-i-samband-med-den-fullt-garanterade-foretradesemissionen-om-cirka-400-miljoner-kronor-bde37ce0 2021-05-25 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-den-23-juni-2021-i-isofol-medical-ab-publ-fb068f52 2021-05-24 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=styrelsen-i-isofol-har-beslutat-om-en-fullt-garanterad-foretradesemission-om-cirka-400-miljoner-kronor-f57a1623 2021-05-18 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kommunike-fran-extra-bolagsstamma-i-isofol-medical-ab-publ-den-14-maj-2021-e33fd2a3 2021-05-14 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-mars-2021-2031c04b 2021-05-14 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2020-207be18a 2021-05-14 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-slutfor-rekryteringen-av-japanska-patienter-i-den-globala-fas-iii-agent-studien-d8d81648 2021-05-06 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-senarelagger-arsstamman-2021-f1d08bab 2021-04-28 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-extra-bolagsstamma-den-14-maj-2021-i-isofol-medical-ab-publ-49d32c33 2021-04-28 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-sin-avsikt-att-genomfora-en-fullt-garanterad-foretradesemission-om-cirka-400-miljoner-kronor-och-en-potentiell-overtilldelningsoption-om-upp-till-cirka-100-miljoner-kronor-54af2569 2021-04-28 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-arsbolagsstamma-den-20-maj-2021-i-isofol-medical-ab-publ-31f66d4d 2021-04-20 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-far-besked-om-att-clinical-use-patent-for-lakemedelskandidaten-arfolitixorin-i-europa-kommer-att-godkannas-546650c1 2021-03-22 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=inbjudan-till-telefonkonferens-och-webcast-i-samband-med-att-isofol-erhaller-rekommendation-att-slutfora-den-globala-fas-iii-agent-studien-med-440-patienter-for-ett-marknadsgodkannande-cbfdaf16 2021-03-22 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=idsmb-rekommenderar-isofol-att-slutfora-den-globala-fas-iii-agent-studien-med-440-patienter-for-ett-marknadsgodkannande-91462348 2021-03-19 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-bokslutskommunike-januari-december-2020-7f05e122 2021-02-26 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-presenterar-idag-genuttrycksresultat-fran-den-slutford-fas-i-iia-iso-cc-005-studien-vid-asco-gi-2021-och-uppdateringar-tidpunkten-for-interimanalysen-i-agent-studien-a2b14c68 2021-01-15 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-nar-440-patienter-i-den-globala-fas-iii-studien-agent-5f0fbcca 2020-12-09 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-att-lars-lind-malin-bjorkmo-bo-lundgren-och-mats-ola-palm-utsetts-som-ledamoter-i-bolagets-valberedning-4e3637c3 2020-11-20 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-september-2020-960c7fb3 2020-11-13 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=inbjudan-till-telefonkonferens-och-webcast-i-samband-med-att-isofol-ingar-licensavtal-med-paladin-labs-inc-for-att-kommersialisera-arfolitixorin-i-kanada-52371086 2020-11-02 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-ingar-licensavtal-med-paladin-labs-inc-for-att-kommersialisera-arfolitixorin-i-kanada-d40543f6 2020-11-02 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=55-objektiv-tumorrespons-hos-extensionskohorterna-i-fas-i-iia-studien-iso-cc-005-0d630348 2020-09-30 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=starkt-patentskydd-for-arfolitixorin-i-japan-8168d5e9 2020-09-01 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-halvarsrapport-januari-juni-2020-aa87b2d4 2020-08-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=inbjudan-till-telefonkonferens-och-webcast-i-samband-med-det-tecknade-licensavtalet-mellan-isofol-och-solasia-b2b4f718 2020-08-13 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-ingar-licensavtal-med-solasia-for-att-utveckla-och-kommersialisera-arfolitixorin-i-japan-ab0eb58d 2020-08-13 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-vd-ulf-jungnelius-har-tecknat-samtliga-teckningsoptioner-2da55cd5 2020-08-04 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=milstolpe-med-330-patienter-inkluderade-i-agent-studien-vilket-oppnar-upp-for-interimanalysen-a1a0236f 2020-07-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=uppdatering-i-agent-studien-med-anledning-av-covid-19-85b4f005 2020-07-10 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kommunike-fran-arsstamma-i-isofol-medical-ab-publ-2020-a9846133 2020-06-24 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-foretradesemission-overtecknad-0dfcb9b4 2020-06-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2019-46779f8f 2020-06-02 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=konsortium-av-investerare-forvarvar-teckningsratter-av-isofols-grundare-professor-bengt-gustavsson-29409e25 2020-05-29 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-i-isofol-medical-ab-publ-b500300a 2020-05-25 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-offentliggor-prospekt-i-samband-med-den-fullt-garanterade-foretradesemissionen-om-cirka-150-miljoner-kronor-437119f1 2020-05-14 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-mars-2020-518d6b12 2020-05-14 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=styrelsen-i-isofol-har-beslutat-om-en-fullt-garanterad-foretradesemission-om-cirka-150-miljoner-kronor-6c1c905c 2020-05-07 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kommunike-fran-extra-bolagsstamma-i-isofol-medical-ab-publ-den-5-maj-2020-92d45417 2020-05-05 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-lakemedelskandidat-arfolitixorin-erhaller-annu-ett-clinical-use-patent-i-usa-003d077c 2020-05-05 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=mojlighet-till-forhandsrostning-vid-extra-bolagsstamma-den-5-maj-2020-1303de57 2020-04-15 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-senarelagger-arsstamman-2020-1e1c501c 2020-04-08 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=information-med-anledning-av-covid-19-9f85795d 2020-04-02 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-extra-bolagsstamma-i-isofol-medical-ab-publ-6a54dc5f 2020-04-01 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-sin-avsikt-att-genomfora-en-fullt-garanterad-foretradesemission-om-cirka-150-miljoner-kronor-och-en-potentiell-overtilldelningsoption-om-upp-till-cirka-30-miljoner-kronor-579ca7f4 2020-03-30 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=genexpressionsdata-fran-ny-analysmetod-stoder-att-storre-andel-av-patienter-kommer-att-ha-nytta-av-arfolitixorin-cbc551e8 2020-03-30 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-bokslutskommunike-januari-december-2019-0582dc01 2020-02-19 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=forsta-patienten-inkluderad-i-japan-i-isofols-fas-iii-agent-studie-4472f21e 2020-02-18 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=metoden-for-genexpressionsanalys-har-validerats-av-ett-kommersiellt-laboratorium-c6b0a5fc 2020-01-30 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=over-200-patienter-har-nu-randomiserats-i-den-globala-fas-iii-agent-studien-4fae0362 2020-01-30 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=fas-i-iia-studien-iso-cc-005-ar-avslutad-56946c3d 2020-01-30 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=forsta-patienten-inkluderad-i-australien-i-isofols-fas-iii-agent-studie-5d7cb316 2020-01-24 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=patent-godkant-i-japan-for-isofols-lakemedelskandidat-arfolitixorin-f0a39105 2019-12-20 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=patentgodkannande-i-usa-for-att-identifiera-hur-patienter-svarar-pa-folatbaserad-cancerbehandling-6c8540c9 2019-12-13 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-att-lars-lind-malin-bjorkmo-bo-lundgren-och-mats-ola-palm-utsetts-som-ledamoter-i-bolagets-valberedning-2cfb0550 2019-12-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-expanderar-den-pagaende-agent-studien-i-forsta-linjens-behandling-av-mcrc-till-australien-1f4b00c6 2019-11-18 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-styrelse-utser-dr-jarl-ulf-jungnelius-som-ny-vd-for-foretaget-ac2c71f1 2019-11-13 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-september-2019-f5d5235d 2019-11-13 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-far-positiv-feedback-fran-pmda-i-japan-och-utvidgar-den-pagaende-globala-och-pivotala-fas-iii-agent-studien-i-forsta-linjens-metastaserande-kolorektalcancer-1f32713c 2019-10-18 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-tillkannager-en-posterpresentation-av-den-globala-fas-iii-studien-med-arfolitixorin-i-metastaserande-kolorektal-cancer-vid-esmo-kongressen-2019-a636ae42 2019-09-29 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-tillkannager-att-ett-abstrakt-har-accepterats-for-presentation-vid-esmo-2019-56180567 2019-09-12 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-halvarsrapport-januari-juni-2019-6c27f02f 2019-08-22 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-utnamner-roger-tell-till-chief-medical-officer-cmo-f924af2f 2019-08-15 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-starker-patentportfoljen-erhaller-clinical-use-patent-i-usa-for-lakemedelskandidaten-arfolitixorin-4d3cd1fd 2019-06-25 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-tillkannager-val-av-tre-nya-styrelseledamoter-a87fb222 2019-06-10 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kommunike-fran-arsstamma-i-isofol-medical-ab-publ-2019-c935cacf 2019-05-24 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-mars-2019-1a24190b 2019-05-23 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-lakemedelskandidat-arfolitixorin-erhaller-clinical-use-patent-i-usa-f887da20 2019-05-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-rapporterar-58-overall-response-rate-hos-patienter-med-metastaserad-kolorektal-cancer-i-en-fas-1-2a-studie-med-arfolitixorin-73998ef8 2019-05-08 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=valkommen-till-arsstamma-i-isofol-medical-ab-publ-b9b1ab85 2019-04-25 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2018-f3a3a873 2019-04-24 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-utser-carnegie-investment-bank-ab-publ-till-finansiell-radgivare-2e8b8a42 2019-02-27 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-bokslutskommunike-januari-december-2018-01bf96d6 2019-02-26 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=samtliga-anstallda-deltar-i-isofols-nyinrattade-teckningsoptionsprogram-1ee27ecc 2019-02-01 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=intervju-med-isofols-styrelseordforande-i-dagens-industris-bilaga-life-science-6d494e2b 2019-01-18 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-rapporterar-tumorkrympning-hos-patienter-med-spridd-kolorektalcancer-efter-8-veckors-behandling-med-arfolitixorin-f62f414f 2019-01-17 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=forsta-patienten-inkluderad-i-isofols-agent-studie-en-pivotal-fas-3-studie-i-forsta-linjens-metastaserande-kolorektal-cancer-6c107653 2018-12-18 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=rapport-fran-extra-bolagsstamma-i-isofol-medical-ab-publ-17-december-2018-614add82 2018-12-17 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-extra-bolagsstamma-i-isofol-medical-ab-publ-2f02d25d 2018-11-26 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-september-2018-3a4da65d 2018-11-23 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-starker-ledningsgruppen-och-utnamner-roger-tell-md-phd-till-chief-scientific-officer-och-senior-vice-president-of-clinical-development-e7227642 2018-11-19 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-utser-robert-marchesani-som-radgivare-till-bolagets-styrelse-ff56ba1d 2018-11-16 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-tillkannager-start-av-pivotal-klinisk-fas-3-studie-med-arfolitixorin-for-behandling-av-metastaserad-kolorektal-cancer-1304ddd4 2018-11-15 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-att-lars-lind-malin-bjorkmo-och-bo-lundgren-utsetts-som-ledamoter-i-bolagets-valberedning-fe50466d 2018-11-08 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=rapport-fran-extra-bolagsstamma-i-isofol-medical-ab-publ-10-oktober-2018-78210dbe 2018-10-10 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=ny-ordforande-och-utokad-styrelse-i-isofol-medical-ab-publ-8502605f 2018-09-11 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-extra-bolagsstamma-i-isofol-medical-ab-publ-81252499 2018-09-11 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-presenterar-pa-pareto-securities-annual-health-care-conference-2018-9daebee0 2018-09-04 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=patent-godkant-i-usa-for-isofols-lakemedelskandidat-arfolitixorin-57afc5ae 2018-08-31 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-halvarsrapport-januari-juni-2018-4521db46 2018-08-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=dagens-industri-publicerar-en-artikel-om-isofol-medical-4ba0b581 2018-07-02 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=redeye-och-isofol-bjuder-in-till-direktsandningen-av-pre-asco-den-28-maj-5bfc4f98 2018-05-24 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-publicerar-delarsrapport-januari-mars-2018-53e5f853 2018-05-16 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-att-ett-abstract-med-nya-forskningsresultat-har-publicerats-infor-arets-asco-kongress-i-chicago-53c8e732 2018-05-15 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=rapport-fran-arsstamma-i-isofol-medical-ab-publ-2018-8a5084ff 2018-05-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-att-en-s-k-sarskild-protokollbedomnings-process-spa-med-fda-pagar-a9769979 2018-05-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2017-d44ceeff 2018-04-13 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-att-ett-abstrakt-rorande-genetikens-inverkan-pa-behandlingsprognos-vid-crc-behandling-skall-presenteras-vid-asco-2018-cd52fab8 2018-04-10 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-i-isofol-medical-ab-publ-07d38a51 2018-04-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-har-valt-dos-pa-lakemedelskandidaten-arfolitixorin-infor-registreringsstudien-iso-cc-007-db96fe33 2018-03-19 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-publicerar-bokslutskommunike-januari-december-2017-a323c2d2 2018-02-20 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-inforlivar-varldshalsoorganisationen-who-s-rekommenderade-generiska-namn-inn-arfolitixorin-for-modufolin-r-414954c2 2018-02-19 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-rapporterar-framgangsrikt-utfall-fran-vetenskapliga-radgivningen-med-ema-1035b12e 2018-02-08 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-vd-styrelsemedlemmar-och-anstallda-tecknar-aktier-for-7-655-136-sek-med-stod-av-tecknings-och-personaloptioner-33eede82 2018-01-24 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=positivt-behandlingsutfall-med-modufolin-r-arfolitixorin-publiceras-pa-cancersymposium-asco-i-usa-d9322c06 2018-01-18 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=framgangsrikt-mote-med-fda-om-fas-ii-avslutningen-och-upplagget-av-fas-iii-studie-for-modufolin-r-2d95c719 2018-01-17 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-tillkannager-positiva-effektdata-for-modufolin-r-arfolitixorin-hos-patienter-som-behandlas-for-metastaserande-kolorektalcancer-5cfb5386 2018-01-11 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-kommer-presentera-pa-arets-uppsattning-av-biotech-showcase-conference-i-san-fransisco-ab5fdf2f 2018-01-04 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-att-ett-abstract-rorande-effekt-av-modufolin-r-vid-behandling-av-kolorektalcancer-presenteras-pa-asco-gi-2018-39081c22 2017-11-27 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-presenterar-pa-stora-aktiedagen-i-goteborg-c7bfe310 2017-11-23 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-presenterar-pa-redeye-life-science-seminar-2017-4f295fe2 2017-11-22 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=delarsrapport-januari-september-2017-89d5b24f 2017-11-20 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-utser-gustaf-albert-till-chief-financial-officer-5b7c6d13 2017-10-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-att-modufolin-r-som-raddningsbehandling-vid-osteosarkom-hos-barn-ar-sakert-och-forebygger-hdmtx-relaterad-toxicitet-2caa8b6e 2017-09-11 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-har-genomfort-ett-framgangsrikt-typ-c-mote-med-amerikanska-fda-gallande-modufolin-r-for-behandling-av-metastaserande-kolorektalcancer-80703716 2017-09-04 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-att-initiala-resultat-fran-pagaende-studien-iso-cc-005-indikerar-effekt-av-modufolin-r-vid-behandling-av-metastaserad-kolorektalcancer-7e8b2891 2017-08-24 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-halvarsrapport-2017-januari-2017-juni-2017-38ad9e73 2017-08-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-utser-dr-sven-erickson-till-chief-commercial-officer-8d36b022 2017-08-18 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-upprattar-samarbete-med-prof-sten-nilsson-och-dr-alain-herrera-som-del-av-forberedelserna-infor-registreringsstudien-med-modufolin-r-6182e70a 2017-08-16 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-att-ett-abstract-om-modufolin-r-vid-osteosarkombehandling-presenteras-pa-esmo-2017-72ba3a00 2017-07-24 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=scrip-intelligence-en-ledande-kalla-for-strategisk-analys-i-lakemedelsindustrin-publicerar-artikel-om-isofol-medical-4790ea2e 2017-07-20 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-har-enrollerat-och-doserat-de-forsta-patienterna-i-ind-studien-iso-ff-001-caea6963 2017-07-05 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=nya-forskningsresultat-starker-isofols-rational-och-motivering-till-att-genomfora-den-pivotala-iso-cc-007-studien-64c581a6 2017-07-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-har-oppnat-fem-ytterligare-studiecentra-i-iso-cc-005-studien-i-vilken-modufolin-r-utvarderas-for-behandling-av-kolorektalcancer-e3815587 2017-06-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-presenterar-pa-smabolagsdagen-12-juni-2017-4d2ca23b 2017-06-08 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-utser-pareto-securities-till-likviditetsgarant-64156c85 2017-05-24 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-meddelar-att-ett-abstract-har-publicerats-infor-arets-asco-kongress-062a1552 2017-05-22 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kommunike-fran-arsstamma-i-isofol-medical-ab-publ-den-16-maj-2017-d953ad60 2017-05-16 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-ab-delarsrapport-q1-2017-januari-2017-mars-2017-bee0e8bd 2017-05-16 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=pareto-securities-har-meddelat-isofol-medical-ab-att-stabiliseringsatgarder-avseende-bolagets-aktier-har-vidtagits-da6b4f91 2017-05-05 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-godkant-for-presentation-av-abstract-pa-arets-asco-kongress-edde1c5a 2017-05-03 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=pareto-securities-har-meddelat-isofol-medical-ab-publ-att-stabiliseringsatgarder-avseende-bolagets-aktier-har-vidtagits-a38e55db 2017-04-25 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=kallelse-till-arsstamma-i-isofol-medical-ab-publ-61fc6043 2017-04-17 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=pareto-securities-har-meddelat-isofol-medical-ab-att-stabiliseringsatgarder-avseende-bolagets-aktier-har-vidtagits-0db6db97 2017-04-12 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-har-framgangsrikt-avslutat-iso-mtx-003-studien-i-vilken-modufolin-utvarderas-som-raddningsterapi-rescue-therapy-692ba7ec 2017-04-11 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-storsta-agare-och-medgrundare-forvarvar-aktier-i-bolaget-7b6f3752 2017-04-04 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-styrelseordforande-forvarvar-aktier-i-bolaget-5369f210 2017-04-04 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-medical-offentliggor-utfallet-av-erbjudandet-handel-pa-nasdaq-first-north-premier-inleds-idag-63c6c0c7 2017-04-04 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=privata-affarer-publicerar-koprekommendation-om-isofol-30f6f4f4 2017-03-29 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=investerarbrevet-publicerar-artikel-om-isofol-034d1d6c 2017-03-28 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=gp-publicerar-artikel-om-isofols-borsnotering-40aa484e 2017-03-28 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=inbjudan-isofol-kommer-presentera-sin-planerade-borsnotering-i-stockholm-29-mars-60157af2 2017-03-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=inbjudan-isofol-kommer-presentera-sin-planerade-borsnotering-i-goteborg-22-mars-eec8092e 2017-03-21 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=notering-av-isofol-medical-pa-nasdaq-first-north-premier-och-offentliggorande-av-prospekt-fc7d661f 2017-03-20 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofols-bokslutskommunike-januari-december-2016-70305fe0 2017-03-20 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-avser-att-noteras-pa-nasdaq-first-north-premier-1c8640f3 2017-03-13 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-ansoker-om-viktigt-patent-i-usa-3fa58263 2017-02-20 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=extra-bolagsstamma-i-isofol-medical-ab-71ed6921 2017-02-08 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=isofol-far-klartecken-fran-fda-att-paborja-kliniskt-program-inom-kolorektalcancer-med-modufolin-r-3211b4f6 2017-01-24 https://investornews.isofolmedical.com/pressmeddelanden/artikel?slug=extra-bolagsstamma-i-isofol-medical-ab-4e47ce84 2016-12-07